ÑÊÀ×ÀÒÜ (17.3 Êá â àðõèâå, ôîðìàò - MS Word) |
|
ÏÐÈ ÏÓÁËÈÊÀÖÈÈ ÌÀÒÅÐÈÀËΠÑÑÛËÊÀ ÍÀ ÈÑÒÎ×ÍÈÊ ÎÁßÇÀÒÅËÜÍÀ !!! |
|
100 ïîëíûõ íàèìåíîâàíèé ëåêàðñòâåííûõ ïðåïàðàòîâ - ëèäåðîâ çà ñåíòÿáðü 2009 ãîäà ïî Ðîññèè
* – ðåéòèíã ïîñòðîåí ïî ñòîèìîñòíûì ïîêàçàòåëÿì îáúåìîâ ïðîäàæ çà ñåíòÿáðü 2009 ãîäà
Èñòî÷íèê: www.dsm.ru
Òîðãîâîå íàèìåíîâàíèå ïðåïàðàòà |
Ïðîèçâîäèòåëü |
Ìåñòî â ðåéòèíãå |
Èçìåíåíèå ê ïðîøëîìó ìåñÿöó |
ÎÖÈËËÎÊÎÊÖÈÍÓÌ ÃÐÀÍ ÃÎÌÅÎÏ 1 ÄÎÇÀ ¹6 |
LABORATOIRES BOIRON |
1 |
+9 |
ÀÐÁÈÄÎË ÊÀÏÑ 100 ÌÃ ¹10 |
ÔÀÐÌÑÒÀÍÄÀÐÒ ÎÎÎ |
2 |
+3 |
ÝÑÑÅÍÖÈÀËÅ ÔÎÐÒÅ Í ÊÀÏÑ 300 ÌÃ ¹30 |
SANOFI-AVENTIS |
3 |
-2 |
ÀÍÀÔÅÐÎÍ ÄÅÒÑÊÈÉ ÒÁ Ä/ÐÀÑÑÀÑ ÃÎÌÅÎÏ ¹20 |
ÌÀÒÅÐÈÀ ÌÅÄÈÊÀ |
4 |
+27 |
ÏÅÍÒÀËÃÈÍ-Í ÒÁ ¹10 |
ÔÀÐÌÑÒÀÍÄÀÐÒ ÎÎÎ |
5 |
+1 |
ÀËÔËÓÒÎÏ Ð-Ð Ä/È 10 ÌÃ/ÌË 1 ÌË ¹10 |
BIOTEHNOS S.A. |
6 |
-4 |
ÒÅÐÀÔËÞ ÎÒ ÃÐÈÏÏÀ È ÏÐÎÑÒÓÄÛ ÏÎÐ Ä/ÎÐÀËÍ Ð-ÐÀ 22,1 Ã ¹10 |
ðàçíûå |
7 |
+45 |
ÏÐÅÄÓÊÒÀË ÌÂ ÒÁ Ñ ÌÎÄÈÔ ÂÛÑÂ Ï/Î 35 ÌÃ ¹60 |
ðàçíûå |
8 |
|
ÀÐÁÈÄÎË ÊÀÏÑ 100 ÌÃ ¹20 |
ÔÀÐÌÑÒÀÍÄÀÐÒ ÎÎÎ |
9 |
+71 |
ÌÅÇÈÌ ÔÎÐÒÅ ÒÁ Ï/Î ¹20 |
A.MENARINI PHARMACEUTICAL INDUSTRY'S GROUP LTD |
10 |
-6 |
ÄÞÔÀÑÒÎÍ ÒÁ 10 ÌÃ ¹20 |
SOLVAY PHARMACEUTICALS B.V. |
11 |
-4 |
ÓÃÎËÜ ÀÊÒÈÂÈÐÎÂÀÍÍÛÉ ÌÑ ÒÁ 250 ÌÃ ¹10 |
ÌÅÄÈÑÎÐÁ ÇÀÎ |
12 |
-9 |
ÊÀÐÑÈË ÄÐÀÆÅ 35 ÌÃ ¹80 |
ðàçíûå |
13 |
+21 |
ÃÅÊÑÎÐÀË ÀÝÐÎÇ ÌÅÑÒÍ 2 ÌÃ/ÌË 40 ÌË ¹1 |
ðàçíûå |
14 |
+14 |
ÍÀÉÇ ÒÁ 100 ÌÃ ¹20 |
DR.REDDY'S LABORATORIES LTD |
15 |
-6 |
ÁÈÎÏÀÐÎÊÑ ÀÝÐÎÇ ÌÅÑÒÍ 125 ÌÊÃ/ÄÎÇÀ 400 ÄÎÇ 20 ÌË ¹1 |
SERVIER |
16 |
+26 |
ÎÌÅÇ ÊÀÏÑ 20 ÌÃ ¹30 |
DR.REDDY'S LABORATORIES LTD |
17 |
-5 |
ÀÊÒÎÂÅÃÈÍ Ð-Ð Ä/È 40 ÌÃ/ÌË 5 ÌË ¹5 |
ðàçíûå |
18 |
-2 |
ÒÅÐÏÈÍÊÎÄ ÒÁ ¹10 |
ÔÀÐÌÑÒÀÍÄÀÐÒ ÎÎÎ |
19 |
-6 |
ËÈÍÅÊÑ ÊÀÏÑ 25 ÌÃ ¹16 |
LEK D.D. |
20 |
-5 |
ÏÐÎÑÒÀÌÎË ÓÍÎ ÊÀÏÑ 320 ÌÃ ¹30 |
A.MENARINI PHARMACEUTICAL INDUSTRY'S GROUP LTD |
21 |
+4 |
ËÈÍÅÊÑ ÊÀÏÑ 25 ÌÃ ¹32 |
LEK D.D. |
22 |
-5 |
ÌÀÃÍÅ B6 ÒÁ Ï/Î ¹50 |
SANOFI-AVENTIS |
23 |
-1 |
ËÈÎÒÎÍ 1000 ÃÅËÜ ÍÀÐÓÆ 1 ÒÛÑ.ÅÄ/ÌË 50 Ã ¹1 |
A.MENARINI PHARMACEUTICAL INDUSTRY'S GROUP LTD |
24 |
-13 |
ÏÎÑÒÈÍÎÐ ÒÁ 0.75 ÌÃ ¹2 |
GEDEON RICHTER |
25 |
-11 |
ÍÎ-ØÏÀ ÒÁ 40 ÌÃ ¹20 |
SANOFI-AVENTIS |
26 |
-5 |
ÌÎÂÀËÈÑ Ð-Ð Ä/È 10 ÌÃ/ÌË 1,5 ÌË ¹3 |
BOEHRINGER INGELHEIM |
27 |
-8 |
ÀÍÀÔÅÐÎÍ ÒÁ Ä/ÐÀÑÑÀÑ ÃÎÌÅÎÏ ¹20 |
ÌÀÒÅÐÈÀ ÌÅÄÈÊÀ |
28 |
- |
ÌÈËÜÃÀÌÌÀ Ð-Ð Ä/È 2 ÌË ¹5 |
ðàçíûå |
29 |
-2 |
ÐÈÍÇÀ ÒÁ ¹10 |
UNIQUE PHARMACEUTICAL LABORATORIES |
30 |
- |
ÃÅÏÒÐÀË ÒÁ Ï/Î 400 ÌÃ ¹20 |
HOSPIRA S.P.A. |
31 |
-13 |
ÀÐÁÈÄÎË ÒÁ Ï/Î 50 ÌÃ ¹10 |
ÔÀÐÌÑÒÀÍÄÀÐÒ ÎÎÎ |
32 |
+61 |
ÑÓÌÀÌÅÄ ÒÁ Ï/Î 0.5 Ã ¹3 |
PLIVA HRVATSKA D.O.O. |
33 |
+5 |
ÑÅÍÀÄÅ ÒÁ 13.5 ÌÃ ¹500 |
CIPLA LTD |
34 |
-10 |
ÒÀÍÒÓÌ ÂÅÐÄÅ ÑÏÐÅÉ ÌÅÑÒÍ 255 ÌÊÃ/ÄÎÇÀ 176 ÄÎÇ 30 ÌË ¹1 |
CSC LTD |
35 |
+23 |
ßÐÈÍÀ ÒÁ Ï/Î ¹21 |
BAYER SCHERING PHARMA AG |
36 |
-13 |
ÍÈÌÅÑÈË ÃÐÀÍ Ä/ÎÐÀËÍ ÑÓÑÏ 100 ÌÃ 2 Ã ¹30 |
A.MENARINI PHARMACEUTICAL INDUSTRY'S GROUP LTD |
37 |
+2 |
ÂÈÀÃÐÀ ÒÁ Ï/Î 100 ÌÃ ¹4 |
PFIZER |
38 |
-8 |
ÄÅÒÐÀËÅÊÑ ÒÁ Ï/Î 0.5 Ã ¹30 |
SERVIER |
39 |
-19 |
ÊÑÈÌÅËÈÍ ÑÏÐÅÉ ÍÀÇÀË 1 ÌÃ/ÌË 15 ÌË ¹1 |
NYCOMED |
40 |
+27 |
ÒÅÐÀÔËÞ ÎÒ ÃÐÈÏÏÀ È ÏÐÎÑÒÓÄÛ ÝÊÑÒÐÀ ÏÎÐ Ä/ÎÐÀËÍ Ð-ÐÀ 21,78 Ã ¹10 |
NOVARTIS |
41 |
- |
ÏÐÅÑÒÀÐÈÓÌ À ÒÁ 5 ÌÃ ¹30 |
SERVIER |
42 |
-16 |
ÂÈÔÅÐÎÍ ÑÓÏÏÎÇ ÐÅÊÒ 150 ÒÛÑ.ÌÅ ¹10 |
ÔÅÐÎÍ ÎÎÎ |
43 |
+16 |
ÑÓÏÐÀÑÒÈÍ ÒÁ 25 ÌÃ ¹20 |
EGIS |
44 |
-15 |
ÀÑÊÎÐÈË ÝÊÑÏÅÊÒÎÐÀÍÒ ÑÈÐÎÏ 100 ÌË ¹1 |
GLENMARK PHARMACEUTICALS LTD |
45 |
- |
ÂÈÀÃÐÀ ÒÁ Ï/Î 100 ÌÃ ¹1 |
PFIZER |
46 |
-13 |
ÊÂÈÍÀÊÑ ÊÀÏËÈ ÃËÀÇ 150 ÌÊÃ/ÌË 15 ÌË ¹1 |
ALCON-COUVREUR |
47 |
-15 |
ÔËÞÊÎÑÒÀÒ ÊÀÏÑ 150 ÌÃ ¹1 |
ÔÀÐÌÑÒÀÍÄÀÐÒ ÎÎÎ |
48 |
-11 |
ÏÅÍÒÀËÃÈÍ-ICN ÒÁ ¹12 |
ÔÀÐÌÑÒÀÍÄÀÐÒ ÎÎÎ |
49 |
-5 |
ÂÎÁÝÍÇÈÌ ÒÁ Ï/Î ¹200 |
MUCOS PHARMA GMBH |
50 |
-7 |
ÀÊÂÀ ÌÀÐÈÑ ÑÏÐÅÉ ÍÀÇÀË 30 ÌË ¹1 |
JADRAN CO |
51 |
- |
ÍÓÐÎÔÅÍ ÏËÞÑ ÒÁ Ï/Î ¹12 |
ðàçíûå |
52 |
-12 |
ÊÐÅÎÍ 10000 ÊÀÏÑ 150 ÌÃ ¹20 |
SOLVAY PHARMACEUTICALS B.V. |
53 |
-12 |
ÄÅÒÐÀËÅÊÑ ÒÁ Ï/Î 0.5 Ã ¹60 |
SERVIER |
54 |
-18 |
ÒÐÎÊÑÅÂÀÇÈÍ ÃÅËÜ ÍÀÐÓÆ 20 ÌÃ/ÌË 40 Ã ¹1 |
ACTAVIS GROUP HF. |
55 |
-20 |
ÄËßÍÎÑ ÑÏÐÅÉ ÍÀÇÀË 1 ÌÃ/ÌË 10 ÌË ¹1 |
NOVARTIS |
56 |
+40 |
ÒÐÎÌÁÎ ÀÑÑ ÒÁ Ï/Î 100 ÌÃ ¹30 |
LANNACHER HEILMITTEL GMBH |
57 |
-12 |
ÀÐÈÔÎÍ ÐÅÒÀÐÄ ÒÁ Ñ ÊÎÍÒÐ ÂÛÑÂ Ï/Î 1.5 ÌÃ ¹30 |
SERVIER |
58 |
-10 |
ÃÐÈÏÏÔÅÐÎÍ ÊÀÏËÈ ÍÀÇÀË 10 ÒÛÑ.ÌÅ/ÌË 10 ÌË ¹1 |
ÔÈÐÍ Ì ÇÀÎ |
59 |
- |
ÔÀÑÒÓÌ ÃÅËÜ ÍÀÐÓÆ 25 ÌÃ/ÌË 50 Ã ¹1 |
A.MENARINI PHARMACEUTICAL INDUSTRY'S GROUP LTD |
60 |
+8 |
ÂÈËÜÏÐÀÔÅÍ ÒÁ Ï/Î 0.5 Ã ¹10 |
ASTELLAS PHARMA INC |
61 |
-7 |
ÖÈÏÐÎÌÅÄ ÊÀÏËÈ ÃËÀÇ 3 ÌÃ/ÌË 5 ÌË ¹1 |
PROMED EXPORTS PVT LTD |
62 |
-7 |
ÍÎËÈÏÐÅË ÔÎÐÒÅ ÒÁ 4 ÌÃ+1.25 ÌÃ ¹30 |
SERVIER |
63 |
-17 |
ÊÎÐÒÅÊÑÈÍ ÏÎÐ ËÔ Ä/È 10 ÌÃ 5 ÌË ¹10 |
ðàçíûå |
64 |
-2 |
ÝÐÅÑÏÀË ÑÈÐÎÏ 2 ÌÃ/ÌË 150 ÌË ¹1 |
SERVIER |
65 |
- |
ÒÅÐÀÔËÞ ÎÒ ÃÐÈÏÏÀ È ÏÐÎÑÒÓÄÛ ÏÎÐ Ä/ÎÐÀËÍ Ð-ÐÀ (ËÅÑÍÛÅ ßÃÎÄÛ) 11,5 à ¹10 |
NOVARTIS |
66 |
- |
ÑÀËÜÁÓÒÀÌÎË ÀÝÐÎÇ Ä/ÈÍÃ 100 ÌÊÃ/ÄÎÇÀ 90 ÄÎÇ 12 ÌË ¹1 |
ðàçíûå |
67 |
-17 |
ÖÅÐÅÁÐÎËÈÇÈÍ Ð-Ð Ä/È 5 ÌË ¹5 |
EBEWE ARZNEIMITTEL GMBH |
68 |
+1 |
ÎÒÐÈÂÈÍ ÑÏÐÅÉ ÍÀÇÀË 1 ÌÃ/ÌË 10 ÌË ¹1 |
NOVARTIS |
69 |
- |
ÂÀÇÅËÈÍ ÂÑÏÎÌÎÃÀÒ Â-ÂÎ - ÌÀÇÅÂ 1 ÊÃ ¹1 |
ÑÏËÀÂ 97 ÎÎÎ |
70 |
- |
ÌÅÊÑÈÄÎË Ð-Ð Ä/È 50 ÌÃ/ÌË 2 ÌË ¹10 |
ðàçíûå |
71 |
-11 |
ÊÀÍÅÔÐÎÍ Í ÄÐÀÆÅ ¹60 |
BIONORICA ARZNEIMITTEL GMBH |
72 |
-23 |
ÄÈÐÎÒÎÍ ÒÁ 10 ÌÃ ¹28 |
GEDEON RICHTER |
73 |
-12 |
ÊÎÍÊÎÐ ÒÁ Ï/Î 5 ÌÃ ¹30 |
NYCOMED |
74 |
-17 |
ÌÅÒÐÎÃÈË ÄÅÍÒÀ ÃÅËÜ ÑÒÎÌÀÒ 20 Ã ¹1 |
UNIQUE PHARMACEUTICAL LABORATORIES |
75 |
-24 |
ÁÈÔÈÔÎÐÌ ÊÀÏÑ ÊÈØÅ×ÍÎÐ ¹30 |
FERROSAN AG |
76 |
-20 |
ÊÎÌÏËÈÂÈÒ ÒÁ Ï/Î ¹60 |
ÔÀÐÌÑÒÀÍÄÀÐÒ ÎÎÎ |
77 |
- |
ÄÅÐÈÍÀÒ Ð-Ð ÍÀÐÓÆ 2.5 ÌÃ/ÌË 10 ÌË ¹1 |
ÒÅÕÍÎÌÅÄÑÅÐÂÈÑ ÔÏ ÇÀÎ |
78 |
- |
ÂÈÇÈÍ ÊÀÏËÈ ÃËÀÇ 0.5 ÌÃ/ÌË 15 ÌË ¹1 |
PFIZER |
79 |
-26 |
ÊÅÒÎÐÎË ÒÁ Ï/Î 10 ÌÃ ¹20 |
DR.REDDY'S LABORATORIES LTD |
80 |
-17 |
ÊÎÄÅËÀÊ ÒÁ ¹10 |
ÔÀÐÌÑÒÀÍÄÀÐÒ ÎÎÎ |
81 |
- |
ÄÈÔËÞÊÀÍ ÊÀÏÑ 150 ÌÃ ¹1 |
PFIZER |
82 |
-16 |
ÄÈÀÁÅÒÎÍ ÌÂ ÒÁ Ñ ÊÎÍÒÐ ÂÛÑÂ 30 ÌÃ ¹60 |
SERVIER |
83 |
-36 |
ÊÎÍÊÎÐ ÒÁ Ï/Î 5 ÌÃ ¹50 |
NYCOMED |
84 |
-20 |
ÁÅÐÎÄÓÀË Í ÀÝÐÎÇ Ä/ÈÍÃ 20 ÌÊÃ+0.5 ÌÃ/ÄÎÇÀ 200 ÄÎÇ 10 ÌË ¹1 |
BOEHRINGER INGELHEIM |
85 |
-9 |
ÏÈÏÎËÜÔÅÍ Ð-Ð Ä/È 25 ÌÃ/ÌË 2 ÌË ¹10 |
EGIS |
86 |
-13 |
ÍÎ-ØÏÀ ÒÁ 40 ÌÃ ¹100 |
SANOFI-AVENTIS |
87 |
-1 |
ÔÅÍÀÇÅÏÀÌ ÒÁ 1 ÌÃ ¹50 |
ðàçíûå |
88 |
-10 |
ÊÎÍÊÎÐ ÊÎÐ ÒÁ Ï/Î 2.5 ÌÃ ¹30 |
NYCOMED |
89 |
-8 |
ÊÀÂÈÍÒÎÍ ÒÁ 5 ÌÃ ¹50 |
GEDEON RICHTER |
90 |
-8 |
ËÀÇÎËÂÀÍ ÑÈÐÎÏ 15 ÌÃ|5 ÌË 100 ÌË ¹1 |
BOEHRINGER INGELHEIM |
91 |
- |
ÈÐÑ-19 ÑÏÐÅÉ ÍÀÇÀË 60 ÄÎÇ 20 ÌË ¹1 |
SOLVAY PHARMACEUTICALS B.V. |
92 |
- |
ÃËÈÖÈÍ ÒÁ ÏÎÄÚßÇÛ× 100 Ìà ¹50 |
ðàçíûå |
93 |
- |
ÝÐÅÑÏÀË ÒÁ Ï/Î 80 ÌÃ ¹30 |
SERVIER |
94 |
- |
ßÐÈÍÀ ÒÁ Ï/Î ¹63 |
BAYER SCHERING PHARMA AG |
95 |
-23 |
ÔÅÐÂÅÊÑ ÏÎÐ Ä/ÎÐÀË Ð-ÐÀ ËÈÌÎÍ Ñ ÑÀÕ 13,1 Ã ¹8 |
BRISTOL-MYERS SQUIBB |
96 |
- |
ÄÈÀÍÅ-35 ÄÐÀÆÅ ¹21 |
BAYER SCHERING PHARMA AG |
97 |
-32 |
ÔËÅÁÎÄÈÀ 600 ÒÁ Ï/Î 600 ÌÃ ¹30 |
LABORATOIRE INNOTECH INTERNATIONAL |
98 |
-24 |
ÌÅÇÈÌ ÔÎÐÒÅ ÒÁ Ï/Î ¹80 |
A.MENARINI PHARMACEUTICAL INDUSTRY'S GROUP LTD |
99 |
-29 |
ÝÍÀÏ ÒÁ 10 ÌÃ ¹20 |
KRKA |
100 |
-9 |